In another retrospective analysis assessing the predictive value of different genomic aberrations in MPM performed by Lo Iacono et al., PIK3CA and TP53 mutations, but not BAP1 mutations, predicted time-to-tumor progression and OS with platinum/pemetrexed (38). This evidence concerns the gene BAP1 and neoplasm.